መነሻ › ሲርሮሲስ › Texas

በTexas ለሲርሮሲስ የሚደረጉ ክሊኒካዊ ጥናቶች

ለሲርሮሲስ የሚደረጉ 13 ጥናቶች በTexas ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በTexas ውስጥ ያሉ ከተሞች

Official study text (English)

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Texas Clinical Research Institute, LLC, Arlington
IMA Clinical Research Austin, Austin
American Research Corporation - Austin, Austin
እና 35 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06632444

A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)

Texas Clinical Research Institute, LLC, Arlington
Epic Medical Research - Carrollton, Carrollton
The Liver Institute at Methodist Dallas, Dallas
እና 5 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07325526

National Liver Cancer Screening Trial

UT Southwestern Medical Center and Parkland Hospital, Dallas
Baylor College of Medicine, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 4

እድሜ ከ18 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06084234

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

Research Site, Austin
Research Site, Denison
Research Site, Georgetown
እና 4 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT07610837

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Liver Center of Texas, Dallas
Methodist Hospital, Richardson

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁላይ 2026 · NCT05181826

Multi-analyte Blood Test Clinical Trial

South Texas Research Institute, Edinburg
Texas Gastro Research, El Paso
Impact Research Institute, Waco

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁላይ 2026 · NCT05199259

High Dose Albumin in Refractory Ascites

Baylor St' Lukes Medical center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁን 2026 · NCT05867602

Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis

UT Health San Antonio, San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ጃንዩ 2026 · NCT06526104

Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs

Baylor College of Medicine (Scott & White), Dallas
Michael E DeBakey VA Medical Center, Houston
Baylor St. Luke's Medical Centre, Houston

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦክቶ 2025 · NCT04613921

Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk

University of Texas Southwestern Medical Center, Dallas

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2025 · NCT05028829

EGCG for Hepatocellular Carcinoma Chemoprevention

UT Southwestern, Dallas

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ሴፕቴ 2025 · NCT06015022

Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics

Methodist Health System, Dallas Medical Center, Dallas
VA North Texas Healthcare System, Dallas
Texas Liver Institute, San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ5 ሴፕቴ 2025 · NCT05490888

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

First Surgical Hospital, Bellaire
Endeavor Clinical Trials, San Antonio

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ14 ኦገስ 2025 · NCT07122700

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።